MAIA Biotechnology (MAIA) Return on Equity [ROE] (2022 - 2026)
MAIA Biotechnology's Return on Equity [ROE] was -119.52% in Q2 2026, up 241.32 percentage points from -360.84% a year earlier and up 51.13 percentage points from the prior quarter.
MAIA Biotechnology (MAIA) Return on Equity [ROE] (2022 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at MAIA Biotechnology came in at -807.58%, up 323.45 percentage points from FY2024.
- Return on Equity [ROE] shows a three-year change of -629.28 percentage points (FY2022 to FY2025).
- In earlier years, Return on Equity [ROE] was -1131.02% in FY2024 (-690.91 pp), -440.12% in FY2023 (-261.82 pp) and -178.29% in FY2022.
- The Q2 2026 figure marks the highest quarterly Return on Equity [ROE] in data going back to Q1 2022.
- Compared with a year earlier, Return on Equity [ROE] was higher in three of the last six quarters, with an average year-over-year change of -158.83 percentage points.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q4 2024 (a gain of 340.79 percentage points); the worst was Q4 2023 (a drop of 1073.18 percentage points).
- Per Business Quant data, MAIA's Return on Equity [ROE] in the three quarters before Q2 2026 was -170.64% (Q1 2026), -1926.08% (Q4 2025) and -1150.30% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.06 Bn | 1,139.65 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 634.89 Bn | 553.42 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 503.32 Bn | 476.44 Bn | 12.70 Bn | - |
| 4 | Merck | 377.44 Bn | 331.82 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 303.91 Bn | 267.90 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 267.03 Bn | 240.72 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 241.88 Bn | 197.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 194.01 Bn | 168.20 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 172.57 Bn | 119.21 Bn | 10.94 Bn | 4.97% |
| 10 | MAIA Biotechnology | 69.31 Mn | -12.25 Mn | - | -119.52% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -119.52% |
| Mar 31, 2026 | -170.64% |
| Dec 31, 2025 | -1,926.08% |
| Sep 30, 2025 | -1,150.30% |
| Jun 30, 2025 | -360.84% |
| Mar 31, 2025 | -459.46% |
| Dec 31, 2024 | -885.35% |
| Sep 30, 2024 | -1,085.22% |
| Dec 31, 2023 | -1,226.14% |
| Sep 30, 2023 | -367.11% |
| Jun 30, 2023 | -295.88% |
| Mar 31, 2023 | -242.40% |
| Dec 31, 2022 | -152.96% |
| Sep 30, 2022 | -154.65% |
| Jun 30, 2022 | -189.03% |
| Mar 31, 2022 | -159.02% |
MAIA Biotechnology Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MAIA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "MAIA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MAIA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();